Abstract:Rationale: While obesity management may be beneficial in the treatment of type 2 diabetes (T2D), achieving weight loss required to achieve these benefits is difficult. New incretin-based options can help treat both conditions, but clinicians lack awareness of and comfort in using these agents. Methods: Vindico provided a continuing education (CE) e-monograph designed for primary care providers (PCPs) and endocrinologists who treat patients with diabetes. Baseline knowledge and behaviors as well as educational impact were assessed via pre- and post-test. Results: A total of 1,692 PCPs and 535 specialists read the monograph. Baseline knowledge was low (average 36% correct) on all topics and was similar between cohorts, except regarding multi-receptor agonism and the impact on weight and A1C, on which specialists scored higher than PCPs (54% vs. 41%). Both cohorts scored lowest regarding the use of incretin-based therapies. Despite this, baseline reported use of incretin-based therapies was high, suggesting that while providers think they are practicing the latest evidence-based care, they may not be. Post-learning, there was 44% relative increase in knowledge, demonstrating large gains in knowledge across cohorts and topics. These knowledge gains translated into 72% of endocrinologists and 70% of PCPs having high levels of post-education confidence regarding the use of new incretin-based options as well as increased preparedness to implement new incretin-based options into practice. Because of the education provided, over 12,000 patients with diabetes and overweight or obesity per week are 56% more likely to receive the latest evidence-based care. Conclusion: In our dataset, providers had inadequate baseline knowledge regarding the burden of obesity in patients with diabetes and new strategies for weight loss. The findings illustrate the benefit of targeted CE on clinician knowledge, behaviors, and confidence towards improved patient outcomes. Disclosure K. Robinson: None. J. Frederick: None. R.A. Esgro: None. H. Collier: None. Funding This activity was supported by an educational grant from Lilly.

It Takes a Brain, a Heart, Courage, and Support

Reflecting on a Year at the Helm of Diabetes Care

The Ailing β-Cell in Diabetes: Insights From a Trip to the ER: The 2023 Outstanding Scientific Achievement Award Lecture

"It Takes a Village"- A Conversation with the Interprofessional Diabetes Clinic at the ECU Health Family Medicine Center

Engineering a Pathway to Glucose-Responsive Therapeutics

Diabetes Team Finalists

Confidence and strength for conquering diabetes

Addressing Therapeutic Inertia in 2020 and Beyond: A 3-Year Initiative of the American Diabetes Association

President's Pen: Embracing the Spirit of Renewal and Compassion

Insulin Action Research and the Future of Diabetes Treatment: The 2017 Banting Medal for Scientific Achievement Lecture

Diabetes Technology in the "Real World": Expanding Access and Addressing Disparities

The 2024 Presidential Address. The power of humility

Diabetes Team Award

Emerging concepts and success stories in type 1 diabetes research: a roadmap for a bright future

Accessibility of diabetes education in the United States: barriers, policy implications, and the road ahead

Diabetes education reimagined: educator-led, technology-enabled diabetes population health management services

"We have dealt with so much. There's more coming?": Improving Knowledge About Brain Health in Adults Living With Congenital Heart Disease

580-P: Dialogues in Diabetes—Addressing Knowledge and Behavior Gaps among Clinicians Who Care for Patients with Diabetes and Obesity

The Emerging Diabetes Online Community

2024 Peggi Guenter excellence in clinical practice lectureship: From curiosity and eagerness to passion: Moving the malnutrition needle

Applying a Solution-Focused Approach to Life With Diabetes: Insights Gleaned via Twitter